Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.
Yahoo
Thursday, September 13, 2012 - 9:29am
tags:
Pfizer, Hisun, Zhejiang Hisun Pharma, Hisun-Pfizer Pharmaceuticals, China, generics
FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis
Yahoo
Wednesday, September 12, 2012 - 10:35pm
tags:
FDA, Genzyme, Sanofi, Aubagio, MS, multiple sclerosis
Sucampo gets UK approval for Amitiza
Yahoo/Fly the on Wall
Wednesday, September 12, 2012 - 7:52pm
tags:
Sucampo, UK, Amitiza
Astex Pharmaceuticals Looks Beyond Dacogen
Motley Fool
Wednesday, September 12, 2012 - 7:32pm
tags:
Dacogen, Astex, AT13387, HSP90 inhibitor
Astex Pharmaceuticals Looks Beyond Dacogen
Motley Fool
Wednesday, September 12, 2012 - 7:32pm
tags:
Dacogen, Astex, AT13387, HSP90 inhibitor
3 Things to Watch With Pfizer's Zoetis IPO
Motley Fool
Wednesday, September 12, 2012 - 7:31pm
tags:
Pfizer, IPOs, Zoetis, animal health
Is the FDA Approving Drugs Too Quickly?
Forbes
Wednesday, September 12, 2012 - 12:44pm
tags:
FDA, drug approvals
Prescriptions for Merck's Singulair Plunge After Loss of U.S. Patent
NASDAQ.com
Wednesday, September 12, 2012 - 12:29pm
tags:
Merck, Singulair, patents, generics
Lundbeck says FDA accepts review of schizophrenia drug
Reuters
Wednesday, September 12, 2012 - 12:28pm
tags:
Lundbeck, FDA, schizophrenia, aripiprazole
Navidea regroups after FDA delays future pharmaceutical sales of cancer imaging agent
Medreps.com
Wednesday, September 12, 2012 - 12:23pm
tags:
Navidea, FDA, Lymphoseek
Biotech M&A Earnout Payments, Data Redux
Forbes
Wednesday, September 12, 2012 - 11:40am
tags:
M&A, biotech
China's 3SBio gets buyout offer from CEO
Reuters
Wednesday, September 12, 2012 - 11:40am
tags:
China, 3SBio, M&A
Dendreon awarded $8M VA contract
FBO.gov
Wednesday, September 12, 2012 - 11:39am
tags:
Dendreon, federal contracts
Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for Gastrointestinal Diseases
Yahoo
Wednesday, September 12, 2012 - 11:34am
tags:
SP-333, Synergy Pharmaceuticals, gastrointestinal
Acadia: A Big Move Into Parkinson's Disease Psychosis Results
Seeking Alpha
Wednesday, September 12, 2012 - 11:33am
tags:
Acadia, Parkinson's Disease Psychosis, pimavanserin, Amarin
Experimental drug curbs smokers' nicotine cravings
Reuters
Wednesday, September 12, 2012 - 11:32am
tags:
smoking cessation, nicotine cravings, GSK, GSK598809
2-Star Stocks Poised to Plunge: Neurocrine Biosciences?
Motley Fool
Wednesday, September 12, 2012 - 11:31am
tags:
Neurocrine Biosciences
Why Risk Is Always Relative in Biotech
Motley Fool
Wednesday, September 12, 2012 - 11:30am
tags:
imetelstat, Geron, stem cells, breast cancer
Cell Therapeutics soars 24% on EU drug launch
Marketwatch
Tuesday, September 11, 2012 - 1:25pm
tags:
Europe, Cell Therapeutics, Pixuvri, non-Hodgkin's lymphoma
Dynavax: The BioRunUp Trade Into An FDA Panel
TheStreet.com
Tuesday, September 11, 2012 - 1:20pm
tags:
FDA, Dynavax, Heplisav, vaccines, hepatitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.